{"id":"68ga-nota-sna002","_chembl":{"chemblId":"CHEMBL5314464","moleculeType":"Protein","molecularWeight":"1535.71"},"modality":"Small molecule","_dailymed":null,"mechanism":{"explanation":"68Ga-NOTA-SNA002 utilizes gallium-68, a positron-emitting radioisotope, conjugated via NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) chelator to a targeting molecule. The compound enables positron emission tomography (PET) imaging by accumulating at specific tissue sites.","oneSentence":"A gallium-68 labeled radiopharmaceutical that binds to specific molecular targets for PET imaging."},"_scrapedAt":"2026-03-28T04:32:14.734Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123353,"model":"claude-sonnet-4-5-20250929"},"description":"68Ga-NOTA-SNA002 is an investigational radiopharmaceutical imaging agent developed by SmartNuclide Biopharma currently in Phase 1 clinical development. It uses gallium-68 radiolabeling with NOTA chelator technology for potential diagnostic imaging applications.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT05989997","phase":"PHASE1","title":"Phase I Clinical Trial of 68Ga-NOTA-SNA002","status":"COMPLETED","sponsor":"SmartNuclide Biopharma","startDate":"2023-11-01","conditions":"Solid Tumor, Positron-Emission Tomography(PET)","enrollment":17},{"nctId":"NCT05490264","phase":"EARLY_PHASE1","title":"[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors","status":"UNKNOWN","sponsor":"SmartNuclide Biopharma","startDate":"2022-10-18","conditions":"Solid Tumor, Positron-Emission Tomography(PET)","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Positron Emission Tomography"],"phase":"phase_1","status":"active","brandName":"68Ga-NOTA-SNA002","genericName":"68Ga-NOTA-SNA002","companyName":"SmartNuclide Biopharma","companyId":"smartnuclide-biopharma","firstApprovalDate":"","aiSummary":"68Ga-NOTA-SNA002 is a protein-based PET tracer used for imaging solid tumors. It is a gallium-68 labeled compound that targets PD-L1 for PET/CT imaging in patients with solid tumors.","enrichmentLevel":2,"visitCount":0,"trialStats":{"total":23,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}